Quantifying the role of adverse events in the mortality difference between first and second-generation antipsychotics in older adults: systematic review and meta-synthesis.
<h4>Background</h4>Observational studies have reported higher mortality among older adults treated with first-generation antipsychotics (FGAs) versus second-generation antipsychotics (SGAs). A few studies examined risk for medical events, including stroke, ventricular arrhythmia, venous...
Guardado en:
Autores principales: | John W Jackson, Sebastian Schneeweiss, Tyler J VanderWeele, Deborah Blacker |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c557cbe88eae476ab9379b55f83097cd |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Schizophrenia Treatment with Second-Generation Antipsychotics: A Multi-Country Comparison of the Costs of Cardiovascular and Metabolic Adverse Events and Weight Gain
por: Kearns B, et al.
Publicado: (2021) -
School types in adolescence and subsequent health and well-being in young adulthood: An outcome-wide analysis.
por: Ying Chen, et al.
Publicado: (2021) -
School types in adolescence and subsequent health and well-being in young adulthood: An outcome-wide analysis
por: Ying Chen, et al.
Publicado: (2021) -
Torsadogenic risk of antipsychotics: combining adverse event reports with drug utilization data across Europe.
por: Emanuel Raschi, et al.
Publicado: (2013) -
Evaluation of the Direct Costs of Managing Adverse Drug Events in all Ages and of Avoidable Adverse Drug Events in Older Adults in Japan
por: Hayato Katsuno, et al.
Publicado: (2021)